Sava Infond D.O.O. Jazz Pharmaceuticals PLC Transaction History
Sava Infond D.O.O.
- $640 Billion
- Q2 2025
A detailed history of Sava Infond D.O.O. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Sava Infond D.O.O. holds 4,200 shares of JAZZ stock, worth $470,736. This represents 0.07% of its overall portfolio holdings.
Number of Shares
4,200
Previous 3,420
22.81%
Holding current value
$470,736
Previous $425 Million
4.97%
% of portfolio
0.07%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
583Shares Held
60.2MCall Options Held
424KPut Options Held
192K-
Black Rock Inc. New York, NY6.15MShares$689 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$674 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$276 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$261 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$220 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.03B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...